SCHEMBL7189033

SCHEMBL7189033

Cc1cccc(Cl)c1C(=O)P(C)(=O)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYK2 P29597 1/20 0.44
FABP3 P05413 1/20 0.42
FABP4 P15090 1/20 0.42
ITGB1 P05556 6/20 0.41
ITGA4 P13612 6/20 0.41
ITGA2 P17301 1/20 0.41
ITGB7 P26010 1/20 0.41
TRPM4 Q8TD43 1/20 0.40
ALDH1A1 P00352 1/20 0.39
KMT2A Q03164 1/20 0.39
PTGS2 P35354 1/20 0.39
MAPT P10636 2/20 0.38
PTK2B Q14289 1/20 0.38
ITGB2 P05107 1/20 0.38
ICAM1 P05362 1/20 0.38
ITGAL P20701 1/20 0.38
CYP2C9 P11712 1/20 0.38
RORC P51449 1/20 0.38
GAA P10253 2/20 0.37
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7189912 0.90 ALDH1A1 (0.44) TYK2ALDH1A1KMT2AMAPTPTK2B
SCHEMBL7175016 0.89 ESR1 (0.41) ALDH1A1KMT2AMAPT
SCHEMBL7179862 0.84 TYK2 (0.44) TYK2FABP3FABP4ITGB1ITGA4
SCHEMBL7182453 0.84 TYK2 (0.44) TYK2FABP3FABP4ITGB1ITGA4
SCHEMBL7174811 0.81 TYK2 (0.44) TYK2FABP3FABP4ITGB1ITGA4
SCHEMBL7181383 0.81 TYK2 (0.42) TYK2FABP3FABP4ITGB1ITGA4
SCHEMBL7182173 0.81 TYK2 (0.42) TYK2FABP3FABP4ITGB1ITGA4
SCHEMBL7182847 0.81 TYK2 (0.42) TYK2FABP3FABP4ITGB1ITGA4
SCHEMBL7182628 0.81 TYK2 (0.42) TYK2FABP3FABP4ITGB1ITGA4
SCHEMBL7183064 0.81 TYK2 (0.42) TYK2FABP3FABP4ITGB1ITGA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1200943-C Organometallic acyl-aryl phosphine CIBA SC HOLDING AG (CH) 2005-05-11 CN disclosed
US-6579663-B2 Chemical intermediates such as lithium 2,6-dimethylbenzoyl phenylphosphine for preparation of acylphosphines, acylphosphine oxides or acylphosphine sulfides CIBA SPECIALTY CHEMICALS CORPORATION 2003-06-17 US disclosed
US-20020107413-A1 Organometallic monoacylarylphosphines WOLF JEAN-PIERRE (CH) 2002-08-08 US disclosed
US-6399805-B2 SUCH AS LITHIUM 2,6-DIMETHYLBENZOYLPHENYLPHOSPHINE, USE AS PHOTOINITIATORS IN PHOTOCURABLE COMPOSITIONS SUCH AS FOR PHOTOGRAPHIC PRODUCTION OF RELIEF IMAGES CIBA SPECIALTY CHEMICALS CORPORATION 2002-06-04 US disclosed
US-20010031898-A1 Organometallic monoacylarylphosphines CIBA SPECIALTY CHEMICALS CORP. 2001-10-18 US disclosed
CN-1308081-A Organometallic acyl-aryl phosphine CIBA SC HOLDING AG (CH) 2001-08-15 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020107413-A1 Organometallic monoacylarylphosphines CBR1, NAF1, DHCR24 TYK2 1285/4885FABP3 3252/4885FABP4 4550/4885
US-20010031898-A1 Organometallic monoacylarylphosphines NAF1, DHCR24, CBR1 TYK2 1333/4885FABP3 2807/4885FABP4 4256/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.